D. E. Shaw & Co., Inc. Novartis Ag Put Options Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $523,985 - $596,585	5,500 New	5,500 $532,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $6.2 Million - $7.59 Million	82,000 Added 188.07%	125,600 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $3.25 Million - $3.8 Million	43,600 New	43,600 $3.31 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $296,407 - $335,294	-3,700 Reduced 5.02%	70,000 $6.14 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $5.58 Million - $6.17 Million	70,000 Added 1891.89%	73,700 $6.45 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $2.97 Million - $3.45 Million	-36,300 Reduced 90.75%	3,700 $303,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $77,737 - $108,911	-1,100 Reduced 2.68%	40,000 $3.3 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $3.47 Million - $3.92 Million	41,100 New	41,100 $3.89 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $1.7 Million - $2.09 Million	-22,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $1.66 Million - $1.85 Million	22,500 New	22,500 $1.93 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.